Premium
[P1–341]: EVALUATE‐AD (ECOLOGICALLY VALID, AMBIENT, LONGITUDINAL AND UNBIASED ASSESSMENT OF TREATMENT EFFICACY IN ALZHEIMER's DISEASE): A PRAGMATIC PROOF‐OF‐CONCEPT CLINICAL TRIAL
Author(s) -
Thomas Neil W.,
Mattek Nora,
Riley Thomas,
Witter Phelps,
Reynolds Christina,
Austin Johanna,
Sharma Nicole,
Kaye Jeffrey
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.06.357
Subject(s) - clinical trial , dementia , cognition , proxy (statistics) , longitudinal study , alzheimer's disease , disease , medicine , psychology , physical medicine and rehabilitation , physical therapy , gerontology , psychiatry , computer science , pathology , machine learning
P1-341 EVALUATE-AD (ECOLOGICALLY VALID, AMBIENT, LONGITUDINAL AND UNBIASED ASSESSMENT OF TREATMENT EFFICACY IN ALZHEIMER’S DISEASE): A PRAGMATIC PROOF-OF-CONCEPT CLINICALTRIAL Neil W. Thomas, Nora Mattek, Thomas Riley, Phelps Witter, Christina Reynolds, Johanna Austin, Nicole Sharma, Jeffrey Kaye, Oregon Health and Science University, Portland, OR, USA; Oregon Health & Science University, Portland, OR, USA. Contact e-mail: nthom047@gmail.com